Skip to main content
Premium Trial:

Request an Annual Quote

A Tale of Two Biotechs

A pair of articles in the Wall Street Journal today look at different forecasts for the two leading biotech companies. Amgen, "the world's largest biotech company by sales," is seeing trouble as safety questions face two of its biggest drugs. "Amgen stock has plunged, wiping out roughly $20 billion in market value since its 52-week high in October," according to this article.

Over at Genentech, meanwhile, life is cheerier. The second-biggest biotech is expected to report a nearly 40 percent spike in sales for the first quarter, this article says.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.